The Seleem Lab based at the Centre for One Health at the
Virginia-Maryland College of Veterinary Medicine, recently received an
NIH grant in collaboration with TAXIS Pharmaceuticals, to support its
work on developing treatments for multidrug-resistant Neisseria
gonorrhoeae, a disease that impacts 120 million people worldwide every
year.